| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3333527 | Seminars in Hematology | 2014 | 8 Pages |
Abstract
Peripheral T-cell lymphomas (PTCLs) are a rare and heterogeneous group of T-cell malignancies characterized by a very poor outcome. The optimal treatment for PTCLs remains controversial. The role of stem cell transplantation in PTCLs has been investigated; however, no randomized control studies specifically dedicated to PTCLs are currently available. Several retrospective and prospective studies have suggested that high-dose chemotherapy (HDT) followed by autologous stem cell transplantation (ASCT) may improve the survival in patients with chemosensitive T-cell lymphoma, either upfront or as salvage treatment. This review provides a summary of the current literature with the intent to explore the role of ASCT in various clinical scenarios.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Perrone Giulia, Paolo Corradini,